The Unyvero platform developed by Curetis is a fast, comprehensive diagnostics system for severe infectious diseases in hospitalized patients.
Using a variety of cartridges, diseases such as pneumonia or implant and tissue infections can be easily and rapidly diagnosed within just four to five hours, whether this is in the laboratory or directly at the "point of need" in the hospital.
Curetis Provides Update on Unyvero LRT FDA 510(k) Submission
Curetis Provides Business and Financial Update for the First Quarter 2017
ATS - American Thoracic Society, Washington D.C., USA - May 19 to 24, 2017
SHEA - The Society for Healthcare Epidemiology of America, St. Louis, MO, USA - May 29 to 30, 2017